Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms.

Bhatia, Divya; Srivastava, Swayam Prakash

Bhatia, Divya; Srivastava, Swayam Prakash.

Afiliación

Bhatia D; Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine, New York, NY, United States.
Srivastava SP; NewYork-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, United States.

Front Pharmacol ; 14: 1252315, 2023.

Article en En | MEDLINE | ID: mdl-37614315

Palabras clave

N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP); diabetic kidney disease; dipeptidyl peptidase-4 (DPP4 or CD26) inhibitors; kidney fibrosis; mitophagy; mitoquinone (MitoQ); sirtuin (SIRT)3; sodium-glucose cotransporter-2 (SGLT2) inhibitors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google